Senti Biosciences Holdings, Inc. - Common Stock (NQ:SNTI)

Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

March 21, 2024

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

January 23, 2024

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

January 22, 2024

Via Benzinga

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

January 05, 2024

Senti Biosciences Inc (NASDAQ: SNTI) received FDA clearance for its Investigational New Drug (IND) application for SENTI-202, an off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cell...

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

December 25, 2023

Via Benzinga

Why Is Blood Cancer Focused Senti Biosciences Stock Trading Higher Today? ↗

December 22, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

December 22, 2023

Via Benzinga

Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

December 22, 2023

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

12 Health Care Stocks Moving In Monday's After-Market Session ↗

December 18, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 12, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

December 12, 2023

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

December 07, 2023

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

November 16, 2023

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Senti Bio Announces Third Quarter 2023 Results and Pipeline Updates

November 13, 2023

Eccogene, a Shanghai-Boston biotech, out-licensed global rights (ex-China) for its novel small molecule GLP-1 agonist to AstraZeneca in a $2 billion blockbuster deal. Eccogene will receive $185 million...

Week In Review: Eccogen Out-Licenses GLP-1 Agonist To AstraZeneca In $2 Billion Deal ↗

November 11, 2023

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

November 08, 2023

Via Benzinga

Crude Oil Falls Sharply; Datadog Shares Spike Higher ↗

November 07, 2023

U.S. stocks traded higher toward the end of trading, with the Nasdaq Composite gaining around 1% on Tuesday The Dow traded up 0.21% to 34,166.89 while the NASDAQ rose 1.09% to 13,666.65. The S&P 500...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 07, 2023

Via Benzinga

Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 07, 2023

Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.

Via Benzinga

Nasdaq Jumps 100 Points; US Trade Deficit Widens In September ↗

November 07, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining more than 100 points on Tuesday The Dow traded up 0.19% to 34,159.14 while the NASDAQ rose 0.84% to 13,631.99. The...

Via Benzinga

Topics Stocks

US Stocks Mixed; D.R. Horton Earnings Top Views ↗

November 07, 2023

U.S. stocks traded mixed this morning, with the Dow Jones falling around 50 points on Tuesday Following the market opening Tuesday, the Dow traded down 0.18% to 34,035.79 while the NASDAQ rose 0.14% to...

Via Benzinga

Topics Stocks

Why Is Cell & Gene Therapy-Focused Senti Biosciences Stock Trading Higher Today? ↗

November 07, 2023

Senti Biosciences Inc (NASDAQ: SNTI) announced a new strategic collaboration with Celest Therapeutics (Shanghai) Co Ltd, a China-based biotechnology company, for the clinical development of SENTI-301A...

Via Benzinga

Why Is Alto Ingredients (ALTO) Stock Down 45% Today? ↗

November 07, 2023

Alto Ingredients stock is falling on Tuesday after the company released a mixed earnings report for the third quarter of the year.

Ventyx Biosciences stock is taking a beating on Tuesday after the company announced it will end development of VTX958 on Phase 2 results.

Why Is Ventyx Biosciences (VTYX) Stock Down 76% Today? ↗

November 07, 2023

Why Alteryx Shares Are Trading Higher By Around 16%; Here Are 20 Stocks Moving Premarket ↗

November 07, 2023

Gainers Senti Biosciences, Inc. (NASDAQ: SNTI) shares surged 120.8% to $0.6450 in pre-market trading after the company reported a new strategic collaboration with Celest Therapeutics for the clinical...

Via Benzinga

Why Is Tharimmune (THAR) Stock Up 113% Today? ↗

November 07, 2023

Tharimmune stock is gaining with heavy trading of THAR shares after the company announced an exclusive worldwide licensing agreement.

Senti Biosciences stock is rising higher on Tuesday as SNTI shares see heavy trading on a strategic collaboration announcement.

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 07, 2023

Via Benzinga

Why Is Senti Biosciences (SNTI) Stock Up 140% Today? ↗

November 07, 2023